{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T03:27:14Z","timestamp":1793762834955,"version":"4.6.1"},"reference-count":119,"publisher":"Elsevier BV","issue":"18","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T00:00:00Z","timestamp":1793750400000},"content-version":"vor","delay-in-days":368,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jacc.2025.08.001","type":"journal-article","created":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T18:22:44Z","timestamp":1756405364000},"page":"1539-1559","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Use of Risk Assessment to Guide Decision-Making for Blood Pressure Management in the Primary Prevention of Cardiovascular Disease: A Scientific Statement From the American Heart Association and American College of Cardiology"],"prefix":"10.1016","volume":"86","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0643-1859","authenticated-orcid":false,"given":"Sadiya S.","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald M.","family":"Lloyd-Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwah","family":"Abdalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie A.","family":"Bello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciantel A.","family":"Blyler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jocelyn","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Commodore-Mensah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith C.","family":"Ferdinand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather M.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Khera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Muntner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacey","family":"Schott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daichi","family":"Shimbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Sidney C.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra J.","family":"Taler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2025.08.001_bib1","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1161\/01.CIR.97.18.1837","article-title":"Prediction of coronary heart disease using risk factor categories","volume":"97","author":"Wilson","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.08.001_bib2","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.08.001_bib3","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1016\/j.jacc.2019.03.010","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"74","author":"Arnett","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.08.001_bib4","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1016\/j.jacc.2018.11.005","article-title":"Use of risk assessment tools to guide decision-making in the primary prevention of atherosclerotic cardiovascular disease: a special report from the American Heart Association and American College of Cardiology","volume":"73","author":"Lloyd-Jones","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"25 Pt B","key":"10.1016\/j.jacc.2025.08.001_bib5","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1016\/j.jacc.2013.11.002","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"63","author":"Stone","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.08.001_bib6","doi-asserted-by":"crossref","first-page":"e285","DOI":"10.1016\/j.jacc.2018.11.003","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"73","author":"Grundy","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.08.001_bib7","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1016\/j.jacc.2017.11.006","volume":"71","author":"Whelton","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.08.001_bib8","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A randomized trial of intensive versus standard blood-pressure control","volume":"373","author":"SPRINT Research Group","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.08.001_bib9","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/S0140-6736(21)00590-0","article-title":"Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis","volume":"397","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.08.001_bib10","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1016\/j.jacc.2017.02.066","article-title":"Using predicted cardiovascular disease risk in conjunction with blood pressure to guide antihypertensive medication treatment","volume":"69","author":"Muntner","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.08.001_bib11","author":"Jones","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.08.001_bib12","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1161\/CIRCULATIONAHA.123.067626","article-title":"Chronic Kidney Disease Prognosis Consortium and the American Heart Association Cardiovascular-Kidney-Metabolic Science Advisory Group. Development and validation of the American Heart Association\u2019s PREVENT equations","volume":"149","author":"Khan","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.08.001_bib13","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0140-6736(24)01028-6","article-title":"Lowering systolic blood pressure to less than 120 mm Hg versus less than 140 mm Hg in patients with high cardiovascular risk with and without diabetes or previous stroke: an open-label, blinded-outcome, randomised trial","volume":"404","author":"Liu","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.08.001_bib14","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1056\/NEJMoa1600175","article-title":"Blood-pressure lowering in intermediate-risk persons without cardiovascular disease","volume":"374","author":"Lonn","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.08.001_bib15","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S0140-6736(21)01921-8","article-title":"Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis","volume":"398","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.08.001_bib16","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","article-title":"2023 ESH guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension","volume":"41","author":"Mancia","year":"2023","journal-title":"J Hypertens"},{"key":"10.1016\/j.jacc.2025.08.001_bib17","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1093\/eurheartj\/ehae178","article-title":"2024 ESC guidelines for the management of elevated blood pressure and hypertension","volume":"45","author":"McEvoy","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2025.08.001_bib18","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1001\/jama.2018.21442","article-title":"Effect of intensive vs standard blood pressure control on probable dementia: a randomized clinical trial","volume":"321","author":"Williamson","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.08.001_bib19","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1001\/jamacardio.2019.6192","article-title":"Assessment of long-term benefit of intensive blood pressure control on residual life span: secondary analysis of the Systolic Blood Pressure Intervention Trial (SPRINT)","volume":"5","author":"Vaduganathan","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2025.08.001_bib20","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1001\/jamainternmed.2017.4377","article-title":"Association between more intensive vs less intensive blood pressure lowering and risk of mortality in chronic kidney disease stages 3 to 5: a systematic review and meta-analysis","volume":"177","author":"Malhotra","year":"2017","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jacc.2025.08.001_bib21","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1161\/HYP.0000000000000053","volume":"68","author":"Iadecola","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.08.001_bib22","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/S0140-6736(22)02603-4","article-title":"Effectiveness of a non-physician community health-care provider-led intensive blood pressure intervention versus usual care on cardiovascular disease (CRHCP): an open-label, blinded-endpoint, cluster-randomised trial","volume":"401","author":"He","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.08.001_bib23","unstructured":"Deleted in proof."},{"key":"10.1016\/j.jacc.2025.08.001_bib24","unstructured":"Deleted in proof."},{"key":"10.1016\/j.jacc.2025.08.001_bib25","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1001\/jamacardio.2024.1449","article-title":"Multifaceted intensive blood pressure control model in older and younger individuals with hypertension: a randomized clinical trial","volume":"9","author":"Guo","year":"2024","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2025.08.001_bib26","unstructured":"Deleted in proof."},{"key":"10.1016\/j.jacc.2025.08.001_bib27","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.028762","article-title":"Stage 1 hypertension and the 10-year and lifetime risk of cardiovascular disease: a prospective real-world study","volume":"12","author":"Peng","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacc.2025.08.001_bib28","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1161\/HYPERTENSIONAHA.123.20900","article-title":"Hypertension statistics for US adults: an open-source web application for analysis and visualization of National Health and Nutrition Examination Survey data","volume":"80","author":"Jaeger","year":"2023","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.08.001_bib29","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1056\/NEJMoa1012848","article-title":"Lifetime risks of cardiovascular disease","volume":"366","author":"Berry","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.08.001_bib30","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1001\/jamacardio.2016.4652","article-title":"Absolute rates of heart failure, coronary heart disease, and stroke in chronic kidney disease: an analysis of 3 community-based cohort studies","volume":"2","author":"Bansal","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2025.08.001_bib31","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0140-6736(15)01225-8","article-title":"Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis","volume":"387","author":"Ettehad","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.08.001_bib32","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1001\/jamacardio.2017.1421","article-title":"Systolic blood pressure reduction and risk of cardiovascular disease and mortality: a systematic review and network meta-analysis","volume":"2","author":"Bundy","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2025.08.001_bib33","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1056\/NEJMoa2412006","article-title":"Intensive blood-pressure control in patients with type 2 diabetes","volume":"392","author":"Bi","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.08.001_bib34","article-title":"SPRINT treatment among adults with chronic kidney disease from 2 large health care systems","volume":"8","author":"Tamura","year":"2025","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jacc.2025.08.001_bib35","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/ejhf.1971","article-title":"Prevention of heart failure events with intensive versus standard blood pressure lowering across the spectrum of kidney function and albuminuria: a SPRINT substudy","volume":"23","author":"Vaduganathan","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2025.08.001_bib36","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report","volume":"106","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.08.001_bib37","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","article-title":"General cardiovascular risk profile for use in primary care: the Framingham Heart Study","volume":"117","author":"D\u2019Agostino","year":"2008","journal-title":"Circulation"},{"issue":"25 Pt B","key":"10.1016\/j.jacc.2025.08.001_bib38","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1016\/j.jacc.2013.11.005","article-title":"2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"63","author":"Goff","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.08.001_bib39","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1161\/CIR.0000000000001191","article-title":"Novel prediction equations for absolute risk assessment of total cardiovascular disease incorporating cardiovascular-kidney-metabolic health: a scientific statement from the American Heart Association","volume":"148","author":"Khan","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.08.001_bib40","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","article-title":"Cardiovascular-kidney-metabolic health: a presidential advisory from the American Heart Association [published correction appears in Circulation. 2024;149:e1023]","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.08.001_bib41","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1001\/jama.2024.12537","article-title":"Projected changes in statin and antihypertensive therapy eligibility with the AHA PREVENT cardiovascular risk equations","volume":"332","author":"Diao","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.08.001_bib42","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-074819","article-title":"Evaluation of clinical prediction models (part 1): from development to external validation","volume":"384","author":"Collins","year":"2024","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2025.08.001_bib43","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.jclinepi.2014.12.013","article-title":"Guideline uptake is influenced by six implementability domains for creating and communicating guidelines: a realist review","volume":"68","author":"Kastner","year":"2015","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jacc.2025.08.001_bib44","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1161\/CIR.0000000000001145","volume":"148","author":"Kwan","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.08.001_bib45","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1161\/CIR.0000000000000071","article-title":"Council on Clinical Cardiology, and Council on Cardiovascular and Stroke Nursing. Status of cardiovascular disease and stroke in Hispanics\/Latinos in the United States: a science advisory from the American Heart Association","volume":"130","author":"Rodriguez","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.08.001_bib46","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.011874","article-title":"Atherosclerotic cardiovascular disease risk prediction in disaggregated Asian and Hispanic subgroups using electronic health records","volume":"8","author":"Rodriguez","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacc.2025.08.001_bib47","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1161\/CIRCULATIONAHA.120.052430","article-title":"Quantifying and understanding the higher risk of atherosclerotic cardiovascular disease among South Asian individuals: results from the UK Biobank prospective cohort study","volume":"144","author":"Patel","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.08.001_bib48","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1001\/jamacardio.2024.2912","article-title":"Tailoring risk prediction models to local populations","volume":"9","author":"Zinzuwadia","year":"2024","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2025.08.001_bib49","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.124.039454","article-title":"Evaluation and comparison of the PREVENT and Pooled Cohort Equations for 10-year atherosclerotic cardiovascular risk prediction","volume":"14","author":"Zhou","year":"2025","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacc.2025.08.001_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/ANNALS-24-00716","article-title":"Development and evaluation of a comprehensive prediction model for incident coronary heart disease using genetic, social, and lifestyle\u2013psychological factors: a prospective analysis of the UK biobank","volume":"178","author":"Naderian","year":"2025","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2025.08.001_bib51","first-page":"e1","article-title":"Performance of the American Heart Association\u2019s PREVENT equations among disaggregated racial and ethnic subgroups","author":"Yan","year":"2025","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2025.08.001_bib52","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1001\/jama.2024.13887","article-title":"Statins for primary prevention of cardiovascular disease: with PREVENT, what\u2019s a clinician to do?","volume":"332","author":"Khan","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.08.001_bib53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002538","article-title":"Blood Pressure Lowering Treatment Trialists\u2019 Collaboration. Blood pressure-lowering treatment strategies based on cardiovascular risk versus blood pressure: a meta-analysis of individual participant data","volume":"15","author":"Karmali","year":"2018","journal-title":"PLoS Med"},{"key":"10.1016\/j.jacc.2025.08.001_bib54","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1111\/jch.13720","article-title":"Effectiveness of blood pressure\u2013lowering treatment by the levels of baseline Framingham risk score: a post hoc analysis of the Systolic Blood Pressure Intervention Trial (SPRINT)","volume":"21","author":"Zhang","year":"2019","journal-title":"J Clin Hypertens"},{"key":"10.1016\/j.jacc.2025.08.001_bib55","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1161\/HYPERTENSIONAHA.121.18315","article-title":"Risk-based intensive blood pressure lowering and prevention of heart failure: a SPRINT post hoc analysis","volume":"78","author":"Molsberry","year":"2021","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.08.001_bib56","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1001\/jamacardio.2021.3187","article-title":"Associations of high-sensitivity troponin and natriuretic peptide levels with outcomes after intensive blood pressure lowering: findings from the SPRINT randomized clinical trial","volume":"6","author":"Berry","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2025.08.001_bib57","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1056\/NEJMoa2111437","article-title":"Trial of intensive blood-pressure control in older patients with hypertension","volume":"385","author":"Zhang","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.08.001_bib58","series-title":"Moving Toward the Next Paradigm for Cardiovascular Prevention","first-page":"1533","author":"Robinson","year":"2016"},{"key":"10.1016\/j.jacc.2025.08.001_bib59","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1161\/CIRCULATIONAHA.115.018383","article-title":"Individualized statin benefit for determining statin eligibility in the primary prevention of cardiovascular disease","volume":"133","author":"Thanassoulis","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.08.001_bib60","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1093\/eurheartj\/ehy653","article-title":"Equalization of four cardiovascular risk algorithms after systematic recalibration: individual-participant meta-analysis of 86 prospective studies","volume":"40","author":"Pennells","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2025.08.001_bib61","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1056\/NEJMms2004740","article-title":"Hidden in plain sight: reconsidering the use of race correction in clinical algorithms","volume":"383","author":"Vyas","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.08.001_bib62","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1136\/bmj.39261.471806.55","article-title":"Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study","volume":"335","author":"Hippisley-Cox","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2025.08.001_bib63","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1161\/HYPERTENSIONAHA.119.14492","article-title":"Discrimination and hypertension risk among African Americans in the Jackson Heart Study","volume":"76","author":"Forde","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.08.001_bib64","first-page":"e41","article-title":"2025 Heart disease and stroke statistics: a report of US and global data from the American Heart Association","volume":"151","author":"Martin","year":"2025","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.08.001_bib65","article-title":"Racial and ethnic differences in prepregnancy hypertension by maternal age","volume":"18","author":"Cameron","year":"2025","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2025.08.001_bib66","doi-asserted-by":"crossref","first-page":"e251","DOI":"10.1161\/CIR.0000000000001000","article-title":"Call to action: maternal health and saving mothers: a policy statement from the American Heart Association","volume":"144","author":"Mehta","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.08.001_bib67","doi-asserted-by":"crossref","first-page":"e143","DOI":"10.1161\/HYP.0000000000000232","article-title":"Implementation strategies to improve blood pressure control in the United States: a scientific statement from the American Heart Association and American Medical Association","volume":"80","author":"Abdalla","year":"2023","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.08.001_bib68","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41569-023-00971-2","article-title":"The case for eliminating racial and ethnic cardiovascular disparities in the USA","volume":"21","author":"Ferdinand","year":"2024","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jacc.2025.08.001_bib69","doi-asserted-by":"crossref","first-page":"e454","DOI":"10.1161\/CIR.0000000000000936","article-title":"Call to action: structural racism as a fundamental driver of health disparities: a presidential advisory from the American Heart Association","volume":"142","author":"Churchwell","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.08.001_bib70","unstructured":"Deleted in proof."},{"key":"10.1016\/j.jacc.2025.08.001_bib71","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.7326\/M23-0507","article-title":"Social, behavioral, and metabolic risk factors and racial disparities in cardiovascular disease mortality in US adults: an observational study","volume":"176","author":"He","year":"2023","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2025.08.001_bib72","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1161\/CIRCULATIONAHA.121.058311","article-title":"Associations of clinical and social risk factors with racial differences in premature cardiovascular disease","volume":"146","author":"Shah","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.08.001_bib73","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1161\/CIRCULATIONAHA.124.071233","article-title":"The role of race in cardiovascular disease risk prediction","volume":"151","author":"Ndumele","year":"2025","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.08.001_bib74","first-page":"e296","volume":"150","author":"Shah","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.08.001_bib75","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.jacc.2018.05.074","article-title":"2017 ACC\/AHA blood pressure treatment guideline recommendations and cardiovascular risk","volume":"72","author":"Colantonio","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.08.001_bib76","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1001\/jamacardio.2022.2345","article-title":"Age at diagnosis of hypertension by race and ethnicity in the US from 2011 to 2020","volume":"7","author":"Huang","year":"2022","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2025.08.001_bib77","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1001\/jamacardio.2019.1746","article-title":"Association of conventional cardiovascular risk factors with cardiovascular disease after hypertensive disorders of pregnancy: analysis of the Nord-Tr\u00f8ndelag Health Study","volume":"4","author":"Haug","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2025.08.001_bib78","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1016\/j.jacc.2022.08.735","article-title":"Intensive blood pressure lowering in patients with malignant left ventricular hypertrophy","volume":"80","author":"Ascher","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.08.001_bib79","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1161\/CIRCULATIONAHA.116.025471","article-title":"Coronary artery calcium to guide a personalized risk-based approach to initiation and intensification of antihypertensive therapy","volume":"135","author":"McEvoy","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.08.001_bib80","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1161\/CIRCULATIONAHA.119.043337","article-title":"Incorporation of biomarkers into risk assessment for allocation of antihypertensive medication according to the 2017 ACC\/AHA high blood pressure guideline: a pooled cohort analysis","volume":"140","author":"Pandey","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.08.001_bib81","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0140-6736(02)08089-3","article-title":"LIFE Study Group. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol","volume":"359","author":"Dahl\u00f6f","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.08.001_bib82","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1161\/CIR.0000000000001162","volume":"148","author":"Dennison Himmelfarb","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.08.001_bib83","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jash.2013.12.006","article-title":"Effect of change in systolic blood pressure between clinic visits on estimated 10-year cardiovascular disease risk","volume":"8","author":"Ye","year":"2014","journal-title":"J Am Soc Hypertens"},{"key":"10.1016\/j.jacc.2025.08.001_bib84","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1472-6963-3-13","article-title":"Physicians\u2019 ability to predict the risk of coronary heart disease","volume":"3","author":"Pignone","year":"2003","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.jacc.2025.08.001_bib85","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/HJR.0b013e3282f13af4","article-title":"Integrated electronic decision support increases cardiovascular disease risk assessment four fold in routine primary care practice","volume":"15","author":"Wells","year":"2008","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"10.1016\/j.jacc.2025.08.001_bib86","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.amepre.2020.07.027","article-title":"Barriers to implementing cardiovascular risk calculation in primary care: alignment with the Consolidated Framework for Implementation Research","volume":"60","author":"Tuzzio","year":"2021","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.jacc.2025.08.001_bib87","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s13012-019-0927-x","article-title":"Implementing cardiovascular disease prevention guidelines to translate evidence-based medicine and shared decision making into general practice: theory-based intervention development, qualitative piloting and quantitative feasibility","volume":"14","author":"Bonner","year":"2019","journal-title":"Implement Sci"},{"key":"10.1016\/j.jacc.2025.08.001_bib88","unstructured":"Deleted in proof."},{"key":"10.1016\/j.jacc.2025.08.001_bib89","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s12913-024-12168-5","article-title":"Lower electronic health record adoption and interoperability in rural versus urban physician participants: a cross-sectional analysis from the CMS quality payment program","volume":"25","author":"Anzalone","year":"2025","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.jacc.2025.08.001_bib90","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1748-5908-6-42","article-title":"The behaviour change wheel: a new method for characterising and designing behaviour change interventions","volume":"6","author":"Michie","year":"2011","journal-title":"Implement Sci"},{"key":"10.1016\/j.jacc.2025.08.001_bib91","doi-asserted-by":"crossref","first-page":"e558","DOI":"10.1161\/CIR.0000000000001107","article-title":"Council on the Kidney in Cardiovascular Disease, and Stroke Council. An overview of telehealth in the management of cardiovascular disease: a scientific statement from the American Heart Association","volume":"146","author":"Takahashi","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.08.001_bib92","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.3399\/bjgp15X683137","article-title":"A cardiovascular educational intervention for primary care professionals in Spain: positive impact in a quasi-experimental study","volume":"65","author":"Gil-Guill\u00e9n","year":"2015","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.jacc.2025.08.001_bib94","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2024.1420274","article-title":"Mobile health apps for cardiovascular risk assessment: a systematic review","volume":"11","author":"Chavez-Ecos","year":"2024","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jacc.2025.08.001_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.socscimed.2021.114321","article-title":"Effectiveness of nudges as a tool to promote adherence to guidelines in healthcare and their organizational implications: a systematic review","volume":"286","author":"Nwafor","year":"2021","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.jacc.2025.08.001_bib96","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1093\/advances\/nmaa041","article-title":"Dietary Approaches to Stop Hypertension (DASH) diet and blood pressure reduction in adults with and without hypertension: a systematic review and meta-analysis of randomized controlled trials","volume":"11","author":"Filippou","year":"2020","journal-title":"Adv Nutr"},{"key":"10.1016\/j.jacc.2025.08.001_bib97","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1001\/archinternmed.2009.470","article-title":"Effects of the DASH diet alone and in combination with exercise and weight loss on blood pressure and cardiovascular biomarkers in men and women with high blood pressure: the ENCORE study","volume":"170","author":"Blumenthal","year":"2010","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2025.08.001_bib99","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11936-019-0724-5","article-title":"Psychosocial stress and cardiovascular disease","volume":"21","author":"Dar","year":"2019","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"10.1016\/j.jacc.2025.08.001_bib100","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1161\/HYPERTENSIONAHA.124.20533","article-title":"Achieving equity in hypertension: a review of current efforts by the American Heart Association","volume":"81","author":"Hardy","year":"2024","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.08.001_bib101","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11883-021-00949-w","article-title":"Social determinants of health and cardiovascular disease: current state and future directions towards healthcare equity","volume":"23","author":"Jilani","year":"2021","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.jacc.2025.08.001_bib102","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2105\/AJPH.2023.307451","article-title":"Built environment and public health: more than 20 years of progress","volume":"114","author":"Rollings","year":"2024","journal-title":"Am J Public Health"},{"key":"10.1016\/j.jacc.2025.08.001_bib103","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1161\/01.cir.0000435173.25936.e1","article-title":"Council for High Blood Pressure Research, and Council on Cardiovascular and Stroke Nursing. Better population health through behavior change in adults: a call to action","volume":"128","author":"Spring","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.08.001_bib104","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ahj.2023.06.014","article-title":"A pragmatic clinical trial assessing the effect of a targeted notification and clinical support pathway on the diagnostic evaluation and treatment of individuals with left ventricular hypertrophy (NOTIFY-LVH)","volume":"265","author":"Berman","year":"2023","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2025.08.001_bib105","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1001\/jamacardio.2024.3649","article-title":"Utility of a systolic blood pressure polygenic risk score with chlorthalidone response","volume":"9","author":"Armstrong","year":"2024","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2025.08.001_bib106","unstructured":"Deleted in proof."},{"key":"10.1016\/j.jacc.2025.08.001_bib107","doi-asserted-by":"crossref","first-page":"e1006","DOI":"10.1161\/CIR.0000000000001307","volume":"151","author":"Khan","year":"2025","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.08.001_bib108","doi-asserted-by":"crossref","DOI":"10.1001\/jamacardio.2025.2427","article-title":"PREVENT: Risk Age equations and population distribution in US adults","author":"Krishnan","year":"2025","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2025.08.001_bib109","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/S0140-6736(13)61752-3","article-title":"The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective","volume":"383","author":"Mahmood","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.08.001_bib110","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.025235","article-title":"Heterogeneity in cardiovascular disease risk factor prevalence among White, African American, African immigrant, and Afro-Caribbean adults: insights from the 2010-2018 National Health Interview Survey","volume":"11","author":"Baptiste","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacc.2025.08.001_bib111","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.027433","article-title":"Heterogeneity in cardiovascular disease risk factors among Latino immigrant subgroups: evidence from the 2010 to 2018 National Health Interview Survey","volume":"12","author":"Elias","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacc.2025.08.001_bib112","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.020408","article-title":"Heterogeneity of cardiovascular disease risk factors among Asian immigrants: insights from the 2010 to 2018 National Health Interview Survey","volume":"10","author":"Koirala","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacc.2025.08.001_bib113","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jacasi.2022.12.010","article-title":"Diabetes-related cardiovascular and all-cause mortality in Asian American subgroups","volume":"3","author":"Shah","year":"2023","journal-title":"JACC Asia"},{"key":"10.1016\/j.jacc.2025.08.001_bib114","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jacasi.2025.01.006","article-title":"Atherosclerotic cardiovascular disease risk prediction models in China, Japan, and Korea: implications for East Asians?","volume":"5","author":"Nguyen","year":"2025","journal-title":"JACC Asia"},{"key":"10.1016\/j.jacc.2025.08.001_bib115","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2021.100251","article-title":"Development and validation of a polysocial risk score for atherosclerotic cardiovascular disease","volume":"8","author":"Javed","year":"2021","journal-title":"Am J Prev Cardiol"},{"key":"10.1016\/j.jacc.2025.08.001_bib116","doi-asserted-by":"crossref","first-page":"369","DOI":"10.18865\/ed.26.3.369","article-title":"Reaching for health equity and social justice in Baltimore: the evolution of an academic-community partnership and conceptual framework to address hypertension disparities","volume":"26","author":"Cooper","year":"2016","journal-title":"Ethn Dis"},{"key":"10.1016\/j.jacc.2025.08.001_bib117","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1377\/hlthaff.2016.0455","article-title":"Insurance churning rates for low-income adults under health reform: lower than expected but still harmful for many","volume":"35","author":"Sommers","year":"2016","journal-title":"Health Aff (Millwood)"},{"key":"10.1016\/j.jacc.2025.08.001_bib118","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jacc.2022.05.001","article-title":"Incorporating cultural competence and cultural humility in cardiovascular clinical trials to increase diversity among participants","volume":"80","author":"Zhu","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.08.001_bib119","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1093\/ajh\/hpab182","article-title":"Proceedings from a National Heart, Lung, and Blood Institute and the Centers for Disease Control and Prevention workshop to control hypertension","volume":"35","author":"Commodore-Mensah","year":"2022","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.jacc.2025.08.001_bib120","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1161\/CIR.0000000000001258","article-title":"Forecasting the economic burden of cardiovascular disease and stroke in the United States through 2050: a presidential advisory from the American Heart Association","volume":"150","author":"Kazi","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.08.001_bib121","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.1161\/CIR.0000000000001256","article-title":"Forecasting the burden of cardiovascular disease and stroke in the United States through 2050\u2014prevalence of risk factors and disease: a presidential advisory from the American Heart Association","volume":"150","author":"Joynt Maddox","year":"2024","journal-title":"Circulation"}],"container-title":["JACC"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109725073425?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109725073425?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T02:45:57Z","timestamp":1793760357000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109725073425"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":119,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0735109725073425"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2025.08.001","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of Risk Assessment to Guide Decision-Making for Blood Pressure Management in the Primary Prevention of Cardiovascular Disease: A Scientific Statement From the American Heart Association and American College of Cardiology","name":"articletitle","label":"Article Title"},{"value":"JACC","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2025.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American College of Cardiology Foundation","name":"copyright","label":"Copyright"}]}}